Zobrazeno 1 - 10
of 29
pro vyhledávání: '"KRISZTINA, BIRÓ"'
Autor:
Zsuzsanna Ujfaludi, Fruzsina Fazekas, Krisztina Biró, Orsolya Oláh-Németh, Istvan Buzogany, Farkas Sükösd, Tamás Beöthe, Tibor Pankotai
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract The imperative need for sensitive and precise tools is underscored in cancer diagnostics, with biomarkers playing a pivotal role in facilitating early detection and tumor diagnosis. Despite their classical pathological classification, testic
Externí odkaz:
https://doaj.org/article/e86b17d6dad54aaabaed0532ec440d24
Autor:
Bertalan Fekete, Lili Bársony, Krisztina Biró, Fruzsina Gyergyay, Lajos Géczi, Attila Patócs, Barna Budai
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background and Objective: Patients with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA) have co-morbidities treated with different drugs. The aim was to quantify the potential effect of co-medications on
Externí odkaz:
https://doaj.org/article/0c7bb170e213471d9f1633cf58e5907d
Autor:
Zsófia Küronya, Tímea Danyi, Tímea Balatoni, Gabriella Liszkay, Erika Tóth, Krisztina Biró, Lajos Géczi
Publikováno v:
Journal of Medical Case Reports, Vol 16, Iss 1, Pp 1-6 (2022)
Abstract Background The use of checkpoint inhibitors has become increasingly important in the treatment of different cancers, including advanced muscle-invasive urothelial cancer and even in basal cell carcinoma. We present the case of a patient with
Externí odkaz:
https://doaj.org/article/90db1b9897ba443a8fa308ec90124416
Autor:
Zsófia Küronya, Georgina Fröhlich, Andrea Ladányi, Tamás Martin, Lajos Géczi, Fruzsina Gyergyai, Orsolya Horváth, Gergő Kiszner, Ágnes Kovács, Tamás Dienes, Enikő Lénárt, Krisztián Nagyiványi, Tibor Szarvas, Mihály Szőnyi, Attila Tóth, Krisztina Biró
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background In Hungary, the mortality rate for testicular germ cell cancer (TGCC) is 0,9/100000 which is significantly higher than the EU average. We prospectively evaluated the effect of socioeconomic position on patient delay and therapy ou
Externí odkaz:
https://doaj.org/article/71f2f09dcb1b4178be049798a5d57614
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Magyar Onkologia; 2023, Vol. 67 Issue 1, p53-58, 6p
Autor:
Zsófia Küronya, Tímea Danyi, Tímea Balatoni, Gabriella Liszkay, Erika Tóth, Krisztina Biró, Lajos Géczi
Publikováno v:
Journal of medical case reports. 16(1)
Background The use of checkpoint inhibitors has become increasingly important in the treatment of different cancers, including advanced muscle-invasive urothelial cancer and even in basal cell carcinoma. We present the case of a patient with advanced
Autor:
Zsófia Küronya, Georgina Fröhlich, Andrea Ladányi, Tamás Martin, Lajos Géczi, Fruzsina Gyergyai, Orsolya Horváth, Gergő Kiszner, Ágnes Kovács, Tamás Dienes, Enikő Lénárt, Krisztián Nagyiványi, Tibor Szarvas, Mihály Szőnyi, Attila Tóth, Krisztina Biró
Background. In Hungary, the mortality rate for testicular germ cell cancer (TGCC) is 7.6% which is significantly higher than the EU average. We prospectively evaluated the effect of socioeconomic status on patient delay, doctor’s delay, and therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7bd2d33e291c591b17e6953e67c6837
https://doi.org/10.21203/rs.3.rs-273912/v1
https://doi.org/10.21203/rs.3.rs-273912/v1
Publikováno v:
Magyar onkologia. 64(3)
The unprecedented development of prostate cancer therapy is a challenge for the proper sequential use of modern medicines. Patients' life expectancies improve when we use treatment lines, one after the other. There is no evidence- based guideline reg